Skip to content

A clinical trial to study the effects of two different treatment methods, hormonal and cellular therapy in patients with fractures.

A study on the role of hormonal and cellular therapy towards acceleration of fracture healing. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055488
Enrollment
15
Registered
2023-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S525- Fracture of lower end of radius

Interventions

Intervention1: teriparatide hormone injection, platelet rich plasma: A subcutaneous PTH injection of 20 µg would be given to group one patients within 3 days of injury. 2ml platelet rich plasma will

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Closed/simple fractures of distal radius

Exclusion criteria

Exclusion criteria: 1. Polytrauma/ Ipsilateral other fractures 2. Joint diseases of ipsilateral wrist, forearm and elbow. 3. Secondary osteoporosis due to any reason. 4. Elevated serum calcium 5. Known allergy to any form of PTH hormone or analogue 6. History of a Malignant neoplasm in the 5 years prior to the study 7. Hb% less than 10gm% 8. Low platelet count 9. Any conditions evidenced to delay normal healing

Design outcomes

Primary

MeasureTime frame
Once the protocol has been applied, the groups will be followed up & outcomes will be assessed by the following methods: 1) Laboratory investigations for serum alkaline phosphatase, serially performed on day 0 within 7 days of admission & 21 days after intervention. 2) Serial radiological examination of wrist, anteroposterior and lateral views on day 0, 10, 18, 4 weeks & 6 weeks. Timepoint: On day 0 within 7 days of admission & 21 days after intervention, and on day 0, 10, 18, 4 weeks & 6 weeks.

Secondary

MeasureTime frame
fracture healing rateTimepoint: at the end of 6 weeks

Countries

India

Contacts

Public ContactShraddha Sawhney

Datta Meghe Institute of Higher Education and Research

sawhneyshraddha17@gmail.com8171100484

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026